首页 | 本学科首页   官方微博 | 高级检索  
     


Role of leptin in the progression of psoriatic,rheumatoid and osteoarthritis
Authors:Jessica Mounessa  Iryna Voloshyna  Amy D Glass  Allison B Reiss
Affiliation:Jessica Mounessa, Iryna Voloshyna, Amy D Glass, Allison B Reiss, Winthrop Research Institute and Department of Medicine, Winthrop-University Hospital, SUNY Stony Brook School of Medicine, Mineola, NY 11501, United States
Abstract:Leptin, an adipokine responsible for body weight regulation, may be involved in pathological processes related to inflammation in joint disorders including rheumatoid arthritis (RA), osteoarthritis, and psoriatic arthritis (PsA). These arthropathies have been associated with a wide range of systemic and inflammatory conditions including cardiovascular disease, obesity, and metabolic syndrome. As a potent mediator of immune responses, leptin has been found in some studies to play a role in these disorders. Furthermore, current potent biologic treatments effectively used in PsA including ustekinumab (an interleukin 12/23 blocker) and adalimumab (a tumor necrosis factor-alpha blocker also used in RA) have been found to increase leptin receptor expression in human macrophages. This literature review aims to further investigate the role leptin may play in the disease activity of these arthropathies.
Keywords:Psoriatic arthritis   Rheumatoid arthritis   Leptin   Ustekinumab   Tumor necrosis factor-alpha
点击此处可从《World Journal of Rheumatology》浏览原始摘要信息
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号